Cargando…
Age-dependent antibody profiles to plasmodium antigens are differentially associated with two artemisinin combination therapy outcomes in high transmission setting
The impact of pre-existing immunity on the efficacy of artemisinin combination therapy is largely unknown. We performed in-depth profiling of serological responses in a therapeutic efficacy study [comparing artesunate-mefloquine (ASMQ) and artemether-lumefantrine (AL)] using a proteomic microarray....
Autores principales: | Andagalu, Ben, Lu, Pinyi, Onyango, Irene, Bergmann-Leitner, Elke, Wasuna, Ruth, Odhiambo, Geoffrey, Chebon-Bore, Lorna J., Ingasia, Luicer A., Juma, Dennis W., Opot, Benjamin, Cheruiyot, Agnes, Yeda, Redemptah, Okudo, Charles, Okoth, Raphael, Chemwor, Gladys, Campo, Joseph, Wallqvist, Anders, Akala, Hoseah M., Ochiel, Daniel, Ogutu, Bernhards, Chaudhury, Sidhartha, Kamau, Edwin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9606348/ https://www.ncbi.nlm.nih.gov/pubmed/36314027 http://dx.doi.org/10.3389/fmed.2022.991807 |
Ejemplares similares
-
The Genotypic and Phenotypic Stability of Plasmodium falciparum Field Isolates in Continuous In Vitro Culture
por: Yeda, Redemptah, et al.
Publicado: (2016) -
Malaria Transmission Dynamics in a High-Transmission Setting of Western Kenya and the Inadequate Treatment Response to Artemether-Lumefantrine in an Asymptomatic Population
por: Andagalu, Ben, et al.
Publicado: (2022) -
Temporal trends in prevalence of Plasmodium falciparum molecular markers selected for by artemether–lumefantrine treatment in pre-ACT and post-ACT parasites in western Kenya
por: Achieng, Angela O., et al.
Publicado: (2015) -
Trends in drug resistance codons in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase genes in Kenyan parasites from 2008 to 2012
por: Juma, Dennis W, et al.
Publicado: (2014) -
A seven-year surveillance of epidemiology of malaria reveals travel and gender are the key drivers of dispersion of drug resistant genotypes in Kenya
por: Maraka, Moureen, et al.
Publicado: (2020)